Safety and Efficacy of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis: A Nationwide Post-Marketing Surveillance Study in Korean Patients
2020 · Advances in Therapy · 36 citations
https://doi.org/10.1007/s12325-020-01328-8
Y
Yangjin Jegal
Ulsan College(KR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
91
Papers
973
Citations
15
h-index
26
i10-index
Yangjin Jegal is an academic researcher from Ulsan College. The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Tuberculosis Research and Epidemiology & Tracheal and airway disorders. The author has an h-index of 15, co-authored 78 publications.
ORCID: 0000-0002-1935-7240Papers by this author
worksClinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
2021 · Tuberculosis & respiratory diseases · 34 citations
https://doi.org/10.4046/trd.2021.0123
Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis
2024 · International Immunopharmacology · 1 citations
https://doi.org/10.1016/j.intimp.2024.112246
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat